These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27542676)

  • 21. Validation of analytic methods for biomarkers used in drug development.
    Chau CH; Rixe O; McLeod H; Figg WD
    Clin Cancer Res; 2008 Oct; 14(19):5967-76. PubMed ID: 18829475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updates on first-line treatment of metastatic pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Strimpakos AS; Syrigos KN; Saif MW
    JOP; 2011 Jul; 12(4):339-42. PubMed ID: 21737891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 42nd Congress of the International Society of Oncology and Biomarkers "ONCOLOGY IN THE BIOMARKER ERA: Biology-Diagnostics-Therapy" ISOBM 2015 : October 3-7, 2015, Hotel Belvedere, Zakopane, POLAND.
    Tumour Biol; 2015 Sep; 36 Suppl 1():1-88. PubMed ID: 26373736
    [No Abstract]   [Full Text] [Related]  

  • 24. Palliative care of pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Saif MW
    JOP; 2011 Jul; 12(4):355-7. PubMed ID: 21737895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designs of preoperative biomarkers trials in oncology: a systematic review of the literature.
    Marous M; Bièche I; Paoletti X; Alt M; Razak AR; Stathis A; Kamal M; Le Tourneau C
    Ann Oncol; 2015 Dec; 26(12):2419-28. PubMed ID: 26371283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings of the 33rd European Society for Medical Oncology Congress. September 12-16, 2008. Stockholm, Sweden.
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii25-325. PubMed ID: 18790942
    [No Abstract]   [Full Text] [Related]  

  • 27. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Brus C; Saif MW
    JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectins in Cancer and Translational Medicine: From Bench to Bedside.
    Bartolazzi A
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261668
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor microenvironment and systemic disease: a dual target in medical oncology (also in the case of biomarkers).
    Melichar B
    Clin Chem Lab Med; 2017 Oct; 55(12):1813-1816. PubMed ID: 29040065
    [No Abstract]   [Full Text] [Related]  

  • 30. How do you distinguish a malignant pelvic mass from a benign pelvic mass? Imaging, biomarkers, or none of the above.
    Moore RG; Bast RC
    J Clin Oncol; 2007 Sep; 25(27):4159-61. PubMed ID: 17698803
    [No Abstract]   [Full Text] [Related]  

  • 31. Biomarkers: a framework driving advances in oncology.
    Nicolini A
    Biomark Med; 2015; 9(4):303-6. PubMed ID: 25808434
    [No Abstract]   [Full Text] [Related]  

  • 32. Highlights of melanoma research presented at the 49th annual meeting of the American Society of Clinical Oncology in Chicago, 2013.
    Krepler C; Herlyn D
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):E1-5. PubMed ID: 24118967
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Kang SP; Saif MW
    JOP; 2010 Jul; 11(4):334-5. PubMed ID: 20601806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abstracts of the 60th Annual Cancer Symposium of the Society of Surgical Oncology. March 15-18, 2007. Washington, DC, USA.
    Ann Surg Oncol; 2007 Feb; 14(2 Suppl):2-119. PubMed ID: 17357218
    [No Abstract]   [Full Text] [Related]  

  • 35. Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Chang BW; Siccion E; Saif MW
    JOP; 2010 Jul; 11(4):313-6. PubMed ID: 20601800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging biomarkers in oncology: we can get more from what we see.
    Chiti A
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(4):535-6. PubMed ID: 25613201
    [No Abstract]   [Full Text] [Related]  

  • 37. Erratum to: Abstract supplement The 42nd Congress of the International Society of Oncology and Biomarkers "ONOCOLOGY IN THE BIOMARKER ERA: Biology - Diagnostics - Therapy" ISOBM 2015 : October 3-7, 2015, Zakopane, POLAND.
    Chechlinska M
    Tumour Biol; 2016 Feb; 37(2):2777-2778. PubMed ID: 26758429
    [No Abstract]   [Full Text] [Related]  

  • 38. Tumor markers as clinical cancer tests--are we there yet?
    Schilsky RL; Taube SE
    Semin Oncol; 2002 Jun; 29(3):211-2. PubMed ID: 12063673
    [No Abstract]   [Full Text] [Related]  

  • 39. Summary of the 2012 American Association for Cancer Research (AACR) Annual Meeting.
    Bae-Jump V; Jazaeri A
    Gynecol Oncol; 2012 Aug; 126(2):174-5. PubMed ID: 22588179
    [No Abstract]   [Full Text] [Related]  

  • 40. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.